1.
Infect Dis (Lond)
; 50(5): 391-394, 2018 05.
Article
in English
| MEDLINE
| ID: mdl-29188735
Subject(s)
Anti-Bacterial Agents/therapeutic use , Cephalosporins/adverse effects , Hospitalization/statistics & numerical data , Penicillanic Acid/analogs & derivatives , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/adverse effects , Cefepime , Cephalosporins/administration & dosage , Cephalosporins/therapeutic use , Escherichia coli/drug effects , Escherichia coli/enzymology , Escherichia coli Infections/drug therapy , Escherichia coli Infections/epidemiology , Female , Humans , India/epidemiology , Klebsiella Infections/drug therapy , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/drug effects , Klebsiella pneumoniae/isolation & purification , Male , Middle Aged , Penicillanic Acid/administration & dosage , Penicillanic Acid/adverse effects , Penicillanic Acid/therapeutic use , Piperacillin/therapeutic use , Tazobactam , Treatment Outcome , Young Adult , beta-Lactamases/biosynthesis , beta-Lactamases/drug effects
2.
Germs
; 7(1): 28-31, 2017 Mar.
Article
in English
| MEDLINE
| ID: mdl-28331839
ABSTRACT
INTRODUCTION: Strongyloidiasis can cause hyperinfection or disseminated infection in an immunocompromised host, and is an important factor linked to enterococcal bacteremia and meningitis. CASE REPORTS: We report two cases highlighting the importance of suspecting Strongyloides hyperinfection syndrome in patients with enterococcal meningitis. CONCLUSION: Our cases highlight the importance of suspecting Strongyloides hyperinfection syndrome in cases of community acquired enterococcal bacteremia and meningitis.
